methotrexate has been researched along with Pleural Effusion, Malignant in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Duan, L; Fan, J; Guo, M; Hu, G; Huang, Q; Jin, Y; Li, Y; Liao, T; Liao, X; Liu, B; Liu, S; Lv, Z; Tang, K; Tao, X; Wang, X; Wu, F; Xu, J; Xu, P; Yang, G; Zhang, S; Zhou, M | 1 |
| Boop, FA; Broniscer, A; Gajjar, A; Klimo, P; Onar-Thomas, A; Panetta, JC; Patay, Z; Qaddoumi, I; Reddick, WE; Robinson, G; Stewart, CF; Ward, D; Wright, KD | 1 |
| Cornelissen, JJ; Schnog, JB; Van Hest, RM; Van't Veer, MB | 1 |
| Gwilt, P; Li, J | 1 |
| Koizumi, W; Nakayama, N; Saigenji, K; Sasaki, T; Tanabe, S | 1 |
| Abbas, A; Barbor, P; Fryer, C; Ghamdi, SA; Khattab, T; Smith, S | 1 |
1 trial(s) available for methotrexate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Effusion, Malignant; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2006 |
5 other study(ies) available for methotrexate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell-Derived Microparticles; Disease Models, Animal; Endocytosis; Humans; Lung Neoplasms; Methotrexate; Mice, Inbred C57BL; Neoplasm Staging; Pleural Effusion, Malignant; Tissue Distribution; Transplantation, Autologous; Tumor Microenvironment | 2019 |
Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.
Topics: Antimetabolites, Antineoplastic; Ascitic Fluid; Central Nervous System Neoplasms; Child, Preschool; Cohort Studies; Combined Modality Therapy; Down-Regulation; Drainage; Female; Humans; Infant; Infant, Newborn; Leucovorin; Male; Metabolic Clearance Rate; Methotrexate; Neuroprotective Agents; Pericardial Effusion; Pleural Effusion, Malignant; Postoperative Complications; Retrospective Studies; Subdural Effusion | 2015 |
Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Drug Interactions; Edema; Etoposide; Female; Humans; Imatinib Mesylate; Leucovorin; Methotrexate; Middle Aged; Piperazines; Pleural Effusion, Malignant; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sodium Potassium Chloride Symporter Inhibitors; Translocation, Genetic | 2008 |
The effect of malignant effusions on methotrexate disposition.
Topics: Antimetabolites, Antineoplastic; Ascitic Fluid; Computer Simulation; Half-Life; Humans; Methotrexate; Models, Biological; Pericardial Effusion; Permeability; Pleural Effusion, Malignant; Rheology | 2002 |
Extramedullary relapse in a child with mixed lineage acute lymphoblastic leukemia: chylous pleuropericardial effusion.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chyle; Chylothorax; Follow-Up Studies; Humans; Leukemia, Biphenotypic, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Pericardial Effusion; Pleural Effusion, Malignant; Remission Induction | 2000 |